Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccination and innate antifungal immunity study
NL-OMON57700Withdrawn
- Sponsor
- Radboud University Medical Center
- Start
- May 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of bcg vaccine in candidiasis, Tuberculosis (TB) and leprosy (HD), sponsored by Radboud University Medical Center. Primary endpoints: Cytokine production, Immune cell phenotype and 3 more. Planned start May 2010; status: withdrawn.
02
Drugs
bcg vaccine
03
Conditions
candidiasisTuberculosis (TB)leprosy (HD)
Beyond the preview
Go deeper on NL-OMON57700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57700.